The Therapeutic Goods Administration (TGA) has released over 95 batches of influenza vaccine, consisting of over 16.8 million doses, for supply in Australia for the 2022 influenza season. This covers batches for both private supply, including through pharmacies, and for Australian Government funded programs.
Eight influenza vaccines are available in Australia in 2022. All of these vaccines are quadrivalent, which means they protect against four strains of influenza. The TGA published in March 2022.
Every year, the TGA reviews the quality of all brands of influenza vaccines seeking to be supplied in the Australian market. The TGA Laboratories have completed batch release assessments of all batches of the 2022 influenza vaccines, confirming that they have met the required standards and no quality issues were identified.
The Department of Health works closely with influenza vaccine manufacturers to ensure timely availability of influenza vaccines for all Australians, particularly those individuals identified at risk. Vaccine manufacturers are responsible for prioritising vaccine supply to individual pharmacies and distributors.
Australians are urged to consult their general practitioner or local immunisation provider to discuss immunisation and how to protect yourself from influenza this year.
